← Open Payments lookup

ALI ALEDHAIM: Open Payments

NPI 1487350039 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,455 in 78 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,211 · 2025 $2,455

Food & beverage: $2,455
CompanyPaymentsAmount
Kestra Medical Technology Services, Inc.10$830
Novo Nordisk Inc12$361
SCPHARMACEUTICALS INC.7$279
E.R. Squibb & Sons, L.L.C.13$217
Lilly USA, LLC5$124
Boehringer Ingelheim Pharmaceuticals, Inc.3$91
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)5$82
Bayer Healthcare Pharmaceuticals Inc.3$70
Esperion Therapeutics, Inc.3$64
PFIZER INC.3$58

Products named: Assure WCD, FUROSCIX, Wegovy, Ozempic, CAMZYOS, ELIQUIS, JARDIANCE, LifeVest.

Industry payments across MD — which companies pay providers there.